Research advances in intestinal flora and the development and prognosis of chronic hepatitis B

VernacularTitle:肠道菌群与慢性乙型肝炎发生发展及预后的关系
Author: Ziwei GUO ^{1
,

2} ; Jiaxin ZHANG ¹ ; Shuo LI ^{1
,

2} ; Xiaobin LI ^{1
,

2} ; Shun ZHU ^{1
,

2} ; Qian JIN ^{1
,

2} ; Xiaoke LI ¹ ; Yongan YE ¹
Author Information

1. Department of Gastroenterology and Hepatology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing 100700, China
2. The First Clinical Medical College of Beijing University of Chinese Medicine, Beijing 100029, China
Publication Type:Reviews
Keywords: Hepatitis B, Chronic; Liver Cirrhosis; Gastrointestinal Microbiome; Fecal Microbiota Transplantation
From: Journal of Clinical Hepatology 2022;38(5):1137-1142
CountryChina
Language:Chinese
Abstract: Intestinal flora is closely associated with chronic hepatitis B (CHB). Recent studies have shown that the imbalance of intestinal flora is associated with the development, progression, and prognosis of CHB, and the environment of intestinal flora may also change with disease progression, suggesting that intestinal flora and CHB interact with each other. This article reviews the influence of intestinal flora on the progression of CHB and related liver diseases and the role of intestinal flora regulation in the diagnosis and treatment of CHB and related liver diseases, in order to provide new ideas for the clinical treatment of CHB.